CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical...
Open-label exposure trial expected to initiate in Q2’24 with NDA filing anticipated in 1H 2025SEATTLE and VANCOUVER, British Columbia, Feb....
— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA...
$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds...
AWRS Actively Pursuing In-Network Commercial Insurance CoverageBRENTWOOD, TN / ACCESSWIRE / February 27, 2024 / Another Way Recovery Services Inc.,...
Innovative Treatment Protocol Aims to Revolutionize Fentanyl TreatmentMIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- For those struggling with fentanyl addiction,...
NEW YORK, NY / ACCESSWIRE / February 21, 2024 / Millions of Americans live with schizophrenia, a complex and long...
Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
TAMPA, FL / ACCESSWIRE / February 21, 2024 / In Black Book Research's annual client experience performance ratings for enterprise...
ORLANDO, FL / ACCESSWIRE / February 21, 2024 / SkywardRx, an innovative digital healthcare consulting company, today announced it has...
BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
As doctors balance the risks and benefits of pain management, PillSafe technology ensures the managed delivery and distribution of controlled...
ST. GEORGE, Utah, Feb. 15, 2024 /PRNewswire/ -- Southwest Behavioral Health Center ("SBHC") is a public provider of comprehensive, integrated...
CHARLOTTESVILLE, VA / ACCESSWIRE / February 15, 2024 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical...
Non-opioid drug candidate from Tonix lowered pain and also improved sleep and fatigueLatest Phase 3 trial achieved primary endpoint (p=0.00005)Potential...
Glen Rock, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”),...
ATLANTA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT...
Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a...
David Dardashti Helping Our Clients is Our Top Priority. Miami, Feb. 10, 2024 (GLOBE NEWSWIRE) -- In light of the...
AURORA, IL / ACCESSWIRE / February 6, 2024 / With the mission of enabling primary care providers to provide comprehensive...